DECIPHER decodes cell types and predicts age from bulk omics
Tested across multiple molecular platforms, the framework separates technical variation from biological signal to infer cell proportions and chronological age across independent human cohorts.
bioRxiv
In a computational study using simulated benchmarks, experimental cell mixtures, and human datasets, researchers developed DECIPHER to infer cell-type composition from bulk omics data across multiple molecular modalities. The framework addresses technical batch effects by learning two distinct components: a domain-constant representation that captures shared biological features and a domain-specific representation that models platform-associated noise. By integrating nonlinear representation learning with differentiable non-negative least-squares optimization, the algorithm estimates cell-type proportions directly from the domain-constant space. Across simulated datasets, experimental cell mixtures, and real-world multi-omics benchmarks, DECIPHER produced robust and competitive deconvolution performance. Beyond identifying cell fractions, the learned domain-constant representations successfully predicted chronological age across independent cohorts and stratified clinical prognosis in lung adenocarcinoma.
Why it matters
Tissues shift in cellular makeup as they age, but bulk molecular profiling masks cell-specific shifts behind aggregate signals. A method that accurately resolves cell types across different omics platforms while preserving biological age signatures helps researchers extract cell-level aging insights from massive existing tissue databases.
Caveats
The study was published as a preprint and has not undergone peer review. As a computational method, its utility depends on the quality of reference datasets and requires further validation across broader prospective cohorts.
The paper
Jinan University
bioRxiv · 29 Sep 2026 · Preprint, not peer-reviewed